No veterinary drug given to Jodhpur hospital; just a case of wrong labelling, says company
Rajasthan government sets up committee to probe administration of injections from vials labelled 'for animal treatment'
Industries can harm health in many ways: Here are 3 that aren’t so obvious
Some products and practices are directly linked to avoidable ill health, planetary damage and social and health inequity, especially by …
Ban FDI in brownfield pharma, says Parliament standing committee
Panel raises alarm over continuing takeover of Indian generic drug firms by multinational companies
The NATCO CL fallout
The compulsory licence granted to Natco may not be a trendsetter but it will shake up the pharmaceuticals market
CAG exposes land scam in Andhra
Government largesse to private enterprises and individuals cost exchequer Rs 1,784 crore
US keeps India out of Priority Foreign Country list of 'worst IP offenders'
US Trade Representative’s Special 301 Report keeps up pressure on India to fall in line with US’ interests
The natco-pfizer test
Natco’s demand for a voluntary licence from Pfizer will establish how well the compulsory licence process works in India
Drug affordability test
Natco’s bid for a compulsory licence to manufacture a Bayer anti-cancer drug is a test of the law’s ‘reasonable price’ …
Karnataka receives lowest solar energy tariff bid till date
Sun Pharma bags solar project by quoting Rs 5.51 per unit; previous lowest bid was for Rs 7 in Odisha
Will appellate body uphold grant of compulsory licence to cancer drug?
Hearing on Bayer's appeal against manufacture of generic version of Nexavar to conclude this week